Clinical Trials Directory

Trials / Completed

CompletedNCT00422734

Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life

Tadalafil 5 mg Once a Day Compared to Placebo in Improving Erectile Dysfunction and Sexual Quality of Life

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
342 (actual)
Sponsor
Eli Lilly and Company · Industry
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

To determine if tadalafil 5 mg daily compared to placebo when given for 12 weeks improves getting and maintaining an erection in men with erectile dysfunction and if there are improvements in the sexual quality of life of the man and his female study partner

Conditions

Interventions

TypeNameDescription
DRUGtadalafil5 mg tadalafil tablet taken by mouth once a day for 12 weeks
DRUGPlaceboplacebo tablet taken by mouth once a day for 12 weeks

Timeline

Start date
2006-11-01
Primary completion
2008-01-01
Completion
2008-01-01
First posted
2007-01-17
Last updated
2009-06-10
Results posted
2009-06-02

Locations

19 sites across 5 countries: United States, Austria, France, Germany, Mexico

Source: ClinicalTrials.gov record NCT00422734. Inclusion in this directory is not an endorsement.